SCHEMBL2225786

SCHEMBL2225786

NS(=O)(=O)c1ccc(OCC(F)(F)F)c(CNc2cc(Nc3ccc(F)cn3)ncn2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 2/20 0.50
TNNI3K Q59H18 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
LMNA P02545 4/20 0.40
ALDH1A1 P00352 1/20 0.40
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
ABL1 P00519 2/20 0.37
BCR P11274 2/20 0.37
HTT P42858 1/20 0.37
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNA2 P20248 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
EGFR P00533 2/20 0.36
ERBB3 P21860 2/20 0.36
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2225876 0.90 BRAF (0.63) BRAFTNNI3KSMN1; SMN2LMNAALDH1A1
SCHEMBL2226948 0.89 BRAF (0.48) BRAFTNNI3KALDH1A1KDM4EGAA
SCHEMBL2227987 0.88 BRAF (0.49) BRAFTNNI3KLMNAKDM4EGAA
SCHEMBL2226257 0.84 TNNI3K (0.49) BRAFTNNI3KSMN1; SMN2LMNAALDH1A1
SCHEMBL2228424 0.83 TNNI3K (0.61) BRAFTNNI3KSMN1; SMN2LMNAALDH1A1
SCHEMBL2225198 0.80 TNNI3K (0.48) BRAFTNNI3KSMN1; SMN2LMNAALDH1A1
SCHEMBL2227178 0.80 TNNI3K (0.61) BRAFTNNI3KSMN1; SMN2LMNAALDH1A1
SCHEMBL14323740 0.77 BRAF (0.81) BRAFTNNI3K
SCHEMBL2225756 0.77 BRAF (0.62) BRAFTNNI3KSMN1; SMN2LMNAALDH1A1
SCHEMBL2226387 0.77 BRAF (0.51) BRAFTNNI3KSMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed